Utility of a Survey Instrument to Predict Benefit From a Novel Treatment for Vertical Heterophoria (VH)
Sponsor: Trinity Health Michigan
A observational or N/A phase clinical study on Binocular Vision Dysfunction and Vertical Heterophoria, this trial is completed. The trial is conducted by Trinity Health Michigan and has accumulated 8 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2017 — Nov 2017 [monthly]
Recruiting NA
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Trinity Health Michigan
- Vision Specialists of Birmingham
For direct contact, visit the study record on ClinicalTrials.gov .